fluoxetine has been researched along with Cytokine Release Syndrome in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creeden, JF | 1 |
| Imami, AS | 1 |
| Eby, HM | 1 |
| Gillman, C | 1 |
| Becker, KN | 1 |
| Reigle, J | 1 |
| Andari, E | 1 |
| Pan, ZK | 1 |
| O'Donovan, SM | 1 |
| McCullumsmith, RE | 1 |
| McCullumsmith, CB | 1 |
1 other study available for fluoxetine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.
Topics: Anti-Inflammatory Agents; COVID-19 Drug Treatment; Cytokine Receptor gp130; Cytokine Release Syndrom | 2021 |